A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [78]
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
A physical map of the DNA regions flanking the rabbit β-globin gene
Jeffreys, A. (1977) · Cell · doi:10.1016/0092-8674(77)90119-2 · Cited by 644
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Chang, E. H., Furth, M. E., Scolnick, E. M., & Lowy, D. R. (1982) · Nature · doi:10.1038/297479a0 · Cited by 587
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine
Witte, O. N., Dasgupta, A., & Baltimore, D. (1980) · Nature · doi:10.1038/283826a0 · Cited by 530
Goff, S. P., Gilboa, E., Witte, O. N., & Baltimore, D. (1980) · Cell · doi:10.1016/0092-8674(80)90554-1 · Cited by 470
Khan, P. M. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(71)80007-3 · Cited by 344
Chromosomal localization of human cellular homologues of two viral oncogenes
Heisterkamp, N., Groffen, J., Stephenson, J. R., Spurr, N. K., Goodfellow, P. N., Solomon, E., Carritt, B., & Bodmer, W. F. (1982) · Nature · doi:10.1038/299747a0 · Cited by 303
Self-citation
Research works printed but not linked: 2
- Heisterkamp, N., Groffen, J. & Stephenson, J. R. J. molec. appl. Genet. (in the press).
- Ferguson-Smith, M. A. & Aitken, D. A. Cytogenet. Cell Genet. 22, 49–451 (1978).
Cited by
Items 401–500 of 1,000
A novel centromeric repetitive DNA from human chromosome 22
Metzdorf, R., G�ttert, E., & Blin, N. (1988) · Chromosoma · doi:10.1007/bf00327372 · Cited by 53
Arnedos, M., Vielh, P. R., Soria, J., & André, F. (2013) · The Journal of Pathology · doi:10.1002/path.4276 · Cited by 54
“Although some cancers harbour frequently recurring alterations in one or a small number of genes (95% of chronic myelogenous leukaemias harbour a translocation between chromosomes 9 and 22, resulting in the BCR–ABL fusion gene [24]), other cancer types exhibit considerable intratumour heterogeneity in the constellatio…”
BackgroundModi, H., Li, L., Chu, S. H., Rossi, J. J., Yee, J.-K., & Bhatia, R. (2010) · Leukemia · doi:10.1038/leu.2010.257 · Cited by 51
Ito, K., Bernardi, R., & Pandolfi, P. P. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.01.004 · Cited by 51
Inhibition and Termination of Physiological Responses by GTPase Activating Proteins
Ligeti, E., Welti, S., & Scheffzek, K. (2012) · Physiological Reviews · doi:10.1152/physrev.00045.2010 · Cited by 72
“The gene of Bcr is subject to crossing over with the gene of Abl tyrosine kinase forming the Philadelphia chromosome, and the fusion protein is involved in development of leukemia (91, 144, 370).”
BackgroundFrequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
Yaghmaie, M., Ghaffari, S. H., Ghavamzadeh, A., Alimoghaddam, K., Jahani, M. M., Mousavi, S.-A., Irvani, M., Bahar, B., & Bibordi, I. (2008) · PubMed · Cited by 51
Salesse, S., Dylla, S. J., & Verfaillie, C. M. (2004) · Leukemia · doi:10.1038/sj.leu.2403310 · Cited by 51
Spurr, N. K., Gough, A. C., Gosden, J. R., Rout, D., Porteous, D. J., van Heyningen, V., & Docherty, A. (1988) · Genomics · doi:10.1016/0888-7543(88)90093-6 · Cited by 51
Self-citationCML vaccines as a paradigm of the specific immunotherapy of cancer
Pinilla-Ibarz, J. A., Cathcart, K. N. S., & Scheinberg, D. A. (2000) · Blood Reviews · doi:10.1054/blre.2000.0127 · Cited by 53
The Philadelphia chromosome: A model of cancer and molecular cytogenetics
Sandberg, A. A., Gemmill, R. M., Hecht, B. K., & Hecht, F. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90039-7 · Cited by 51
the Inter-Michinoku Dasatinib Study Group (IMIDAS), Ishida, Y., Murai, K., Yamaguchi, K., Miyagishima, T., Shindo, M., Ogawa, K., Nagashima, T., Sato, S., Watanabe, R., et al. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1968-y · Cited by 51
Veeraraghavan, J., Ma, J., Hu, Y., & Wang, X.-S. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3876-y · Cited by 52
Aoki, S., Kong, D., Matsui, K., Rachmat, R., & Kobayashi, M. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.935 · Cited by 50
Bhatia, R., Munthe, H. A., & Verfaillie, C. M. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00084-3 · Cited by 50
Zhong, S., Spurr, N. K., Hayes, J. D., & Wolf, C. R. (1993) · Biochemical Journal · doi:10.1042/bj2910041 · Cited by 50
Self-citationWessels, J. W., Fibbe, W. E., van der Keur, D., Landegent, J. E., van der Plas, D. C., Ottolander, G. J. D., Roozendaal, K. J., & Beverstock, G. C. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90051-m · Cited by 50
bcr rearrangement in Ph-negative CML
Bartram, C. R., & Carbonell, F. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90046-4 · Cited by 50
Self-citationNeoplasia and Cytogenetic Abnormalities
Evans, H. J. (1985) · Springer eBooks · doi:10.1007/978-1-4613-2127-9_11 · Cited by 50
NUP214 fusion genes in acute leukemia (Review)
Zhou, M., & YANG, Q.-M. (2014) · Oncology Letters · doi:10.3892/ol.2014.2263 · Cited by 49
Maru, Y., Peters, K. L., Afar, D., Shibuya, M., Witte, O. N., & Smithgall, T. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.835 · Cited by 49
“This translocation fuses the c-abl proto-oncogene on chromosome 9 with the bcr locus on chromosome 22, resulting in the formation of a chimeric bcr-abl oncogene (8, 15, 21, 52).”
BackgroundRecurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment
Wang, Y., Wu, N., Liu, D., & Jin, Y. (2017) · Current Genomics · doi:10.2174/1389202918666170329110349 · Cited by 49
“cn his colleagues identified that the translocation involved ABL on the distal end of the q-arms of chromosome 9 and the gene breakpoint on the breakpoint cluster region (BCR) of chromosome 22 in 1982 [3].”
BackgroundInfluentialInterphase Cytogenetic Analysis of Solid Tumors by Non-Isotopic DNA in situ Hybridization
Alers, J. C., & van Dekken, H. (1996) · Progress in Histochemistry and Cytochemistry · doi:10.1016/s0079-6336(96)80017-9 · Cited by 50
Chromosomal translocation master genes, mouse models and experimental therapeutics
Rabbitts, T. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204597 · Cited by 51
“This resulted in a fusion gene, analogous to the BCR±ABL gene which had ®rst been described in chronic myelogenous leukaemia (de Klein et al., 1982), encoding an FUS±CHOP protein.”
ResultImatinib mesylate in the treatment of chronic myeloid leukaemia
Druker, B. J. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.6.963 · Cited by 54
Trisomy 12 in benign fibroma and granulosa cell tumor of the ovary
Leung, W., Schwartz, P. E., Ng, H., & Yang‐Feng, T. L. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90006-7 · Cited by 48
Saglio, G. N., Guerrasio, A., Tassinari, A., Ponzetto, C., Zaccaria, A., Pp, T., Celso, B., Cambrin, G. R., Serra, A., & Pegoraro, L. (1988) · Blood · doi:10.1182/blood.v72.4.1203.1203 · Cited by 48
Products of a reciprocal chromosome translocation involving the c-myc gene in a murine plasmacytoma.
Stanton, L. W., Yang, J. Q., Eckhardt, L. A., Harris, L. J., Birshtein, B. K., & Marcu, K. B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.829 · Cited by 48
Kim, J., Kim, S., Ko, S., In, Y.-H., Moon, H., Ahn, S. K., Kim, M. K., Lee, M., Hwang, J., Ju, Y. S., et al. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22279 · Cited by 53
“The BCR-ABL1 fusion gene, which is a prototypic fusion oncogene associated with leukemia, has proven to be an efficient therapeutic target for tyrosine kinase inhibitors which yield significant survival gains in leukemia patients (Rowley, 1973; de Klein et al., 1982).”
BackgroundGroffen, J., & Heisterkamp, N. (1987) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(87)80035-5 · Cited by 53
Self-citationHigh resolution chromosomes of the t(9;22) positive leukemias
Prakash, O., & Yunis, J. J. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90015-3 · Cited by 47
Bartram, C., Raghavachar, A., Anger, B., Stain, C., & Bettelheim, P. (1987) · Blood · doi:10.1182/blood.v69.6.1682.1682 · Cited by 47
Self-citationGreen, A. R., & Wyke, J. A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90404-0 · Cited by 47
Orlando, E., Aebersold, D. M., Medová, M., & Zimmer, Y. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.12.001 · Cited by 47
The molecular biology and therapeutic potential of Nrf2 in leukemia
Khodakarami, A., Adibfar, S., Karpisheh, V., Abolhasani, S., Jalali, P., Mohammadi, H., Navashenaq, J. G., Hojjat‐Farsangi, M., & Jadidi‐Niaragh, F. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02660-5 · Cited by 47
“CML is more common in adults but also rare in children [174, 175].”
BackgroundHunger, S. P. (2011) · Hematology · doi:10.1182/asheducation-2011.1.361 · Cited by 52
Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
Alikian, M., Gale, R. P., Apperley, J. F., & Foroni, L. (2017) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2017.01.001 · Cited by 55
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors
Yaghmaie, M., & Yeung, C. C. S. (2019) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-019-00543-7 · Cited by 50
Classification of chronic myeloid disorders: From Dameshek towards a semi-molecular system
Tefferi, A., & Gilliland, G. D. (2006) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.07.001 · Cited by 60
Krämer, A., Hörner, S., Willer, A., Früehauf, S., Hochhaus, A., Hallek, M. J., & Hehlmann, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2087 · Cited by 56
Apoptosis in the development of the immune system: Growth factors, clonal selection and bcl-2
McCarthy, N., Smith, C. A., & Williams, G. T. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf00048062 · Cited by 46
“Specific chromosomal aberrations are often associated with human lymphoid tumours, for example, the Philadelphia chromosome which is produced by a 9;22 translocation and found in patients with chronic myeloid leukaemia [108].”
BackgroundAutologous Transplantation Therapy for Chronic Myelogenous Leukemia
Bhatia, R., Verfaillie, C. M., Miller, J. S., & McGlave, P. B. (1997) · Blood · doi:10.1182/blood.v89.8.2623 · Cited by 46
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
Patel, J. N. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s62918 · Cited by 55
Biology-driven cancer drug development: back to the future
Lord, C. J., & Ashworth, A. (2010) · BMC Biology · doi:10.1186/1741-7007-8-38 · Cited by 52
The molecular basis for paroxysmal nocturnal hemoglobinuria
Yomtovían, R., Prince, G. M. S. H., & Medof, M. E. (1993) · Transfusion · doi:10.1046/j.1537-2995.1993.331094054626.x · Cited by 45
Chen, S., O’Reilly, L. P., Smithgall, T. E., & Engen, J. R. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.040 · Cited by 44
“The second form, called c-Abl (2), contained more of the NCap and based on MS analysis (data not shown) was stoichiometrically myristoylated at Gly2 as shown originally by Nagar et al.”
BackgroundMethodInfluentialSTI571: A gene product-targeted therapy for leukemia
Mauro, M. J., & Druker, B. J. (2001) · Current Oncology Reports · doi:10.1007/s11912-001-0054-z · Cited by 44
Zhao, Z., Tang, X., You, Y., Li, W., Liu, F., & Zou, P. (2006) · Leukemia Research · doi:10.1016/j.leukres.2005.12.010 · Cited by 44
A new oncogene, c-raf, is located on mouse chromosome 6
Kozak, C. A., Gunnell, M., & Rapp, U. R. (1984) · Journal of Virology · doi:10.1128/jvi.49.1.297-299.1984 · Cited by 44
“Perhaps the most intriguing was the finding that c-onc genes may be activated by their translocation to transcriptionally active chromosomal regions (4, 5, 25, 26).”
BackgroundLandstrom, A. P., & Tefferi, A. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500353133 · Cited by 44
Molecular characteristics of chronic myelogenous leukemia in blast crisis
Blick, M. B., Romero, P., Talpaz, M., Kurzrock, R., Shtalrid, M., Andersson, B. S., Trujillo, J. M., Beran, M., & Gutterman, J. U. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90018-5 · Cited by 44
Marega, M., Piazza, R., Pirola, A., Redaelli, S., Mogavero, A., Iacobucci, I., Meneghetti, I., Parma, M., Pogliani, E. M., & Gambacorti-Passerini, C. B. (2010) · Leukemia · doi:10.1038/leu.2010.101 · Cited by 43
Luthra, R., Sánchez-Vega, B., & Medeiros, L. J. (2003) · Modern Pathology · doi:10.1038/modpathol.3800026 · Cited by 43
Human cellular retinol‐binding protein gene organization and chromosomal location
NILSSON, M. H. L., Spurr, N. K., Lundvall, J., Rask, L., & Peterson, P. A. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13963.x · Cited by 45
Self-citationEssential thrombocythaemia and the Philadelphia chromosome
Morris, C. M., Fitzgerald, P. H., Hollings, P. E., Archer, S. A., Rosman, I., Beard, M. E. J., Heaton, D. C., & Newhook, C. J. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb02427.x · Cited by 43
Omics and therapy – A basis for precision medicine
Garay, J. P., & Gray, J. W. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.02.009 · Cited by 52
“Therefore it was nearly 25 years betweendiscovery of thepathogenic translocation and identification of the genes involved (de Klein et al., 1982; Groffen et al., 1984).”
BackgroundStructural and Functional Chimerism Results from Chromosomal Translocation in Lymphoid Tumors
Rabbitts, T. H., & Boehm, T. L. J. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60824-x · Cited by 43
DAP genes: novel apoptotic genes isolated by a functional approach to gene cloning
Kimchi, A. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00002-x · Cited by 57
van Kessel, A. G., Turc‐Carel, C., de Klein, A., Grosveld, G. C., Lenoir, G., & Bootsma, D. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.2.427 · Cited by 42
Self-citationSmetsers, T. F. C. M., Locht, L. T. F. V. D., Pennings, A. H. M., Wessels, H. M. C., de Witte, T. M., & Mensink, E. J. B. M. (1995) · PubMed · Cited by 42
Restricted And-Parallelism and Side Effects.
DeGroot, D. (1987) · SLP · Cited by 42
Kasper, B., Fruehauf, S., Schiedlmeier, B., Buchdunger, E., Ho, A. D., & Zeller, W. J. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051001 · Cited by 42
“The disease is characterized by the reciprocal translocation (9;22)(q34;q11) with fusion of the bcr and abl genes [ 20 ] resulting in an abnormally short chromosome 22, the so-called Philadelphia (Ph) chromosome.”
BackgroundThe bcr gene in Philadelphia chromosome positive acute lymphoblastic leukemia
Heisterkamp, N., Jenkins, R. B., Thibodeau, S. N., Testa, J., Weinberg, K. I., & Groffen, J. (1989) · Blood · doi:10.1182/blood.v73.5.1307.1307 · Cited by 42
Self-citationSiegers, G. M., Felizardo, T. C., Mathieson, A. M., Kosaka, Y., Wang, X., Medin, J. A., & Keating, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016700 · Cited by 41
Partial cooperative unfolding in proteins as observed by hydrogen exchange mass spectrometry
Engen, J. R., Wales, T. E., Chen, S., Marzluff, E. M., Hassell, K. M., Weis, D. D., & Smithgall, T. E. (2012) · International Reviews in Physical Chemistry · doi:10.1080/0144235x.2012.751175 · Cited by 44
Localisation of the human N‐ras oncogene to chromosome 1cen ‐ p21 by in situ hybridisation.
Davis, M. B., Malcolm, S., Hall, A., & Marshall, C. J. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01735.x · Cited by 41
Bernstein, R., Pinto, M. R., Wallace, C., Penfold, G. K., & Mendelow, B. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90034-7 · Cited by 41
Buchner, M., Swaminathan, S., Chen, Z., & Müschen, M. (2014) · Immunological Reviews · doi:10.1111/imr.12235 · Cited by 45
“Three different breakpoint cluster regions in the BCR gene have been reported, which result in different transcripts, namely p190 and p210, and p230 (106, 107).”
BackgroundAffer, M., Dao, S., Liu, C., Olshen, A. B., Mo, Q., Viale, A. J., Lambek, C. L., Marr, T. G., & Clarkson, B. (2011) · Journal of Oncology · doi:10.1155/2011/798592 · Cited by 41
“Hindawi Publishing Corporation Journal of Oncology Volume 2011, Article ID 798592, 25 pages doi:10.1155/2011/798592”
BackgroundInfluentialChen, P., Liu, A.-J., Ho, K., Chiu, Y.-T., Lin, Z.-H. A., Lee, Y., Shih, C.-M., & Chen, K. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.06.006 · Cited by 40
Collins, S., & Groudine, M. T. (1987) · Blood · doi:10.1182/blood.v69.3.893.893 · Cited by 40
Bhatia, R., & Verfaillie, C. M. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809092680 · Cited by 41
bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia.
Bartram, C. R. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.6.2175 · Cited by 40
Self-citationCytogenetics of chronic myeloid leukaemia
Chase, A., Huntly, B. J. P., & Cross, N. C. P. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2001.0154 · Cited by 40
Acromegaly and gastrointestinal cancer
Ron, E., Gridley, G., Hrubec, Z., Page, W., Arora, S., & Fraumeni, J. F. (1991) · Cancer · doi:10.1002/1097-0142(19911015)68:8<1673::aid-cncr2820680802>3.0.co;2-0 · Cited by 250
Comparative map for mice and humans
Nadeau, J. H., Davisson, M. T., Doolittle, D. P., Grant, P., Hillyard, A. L., Kosowsky, M., & Roderick, T. H. (1991) · Mammalian Genome · doi:10.1007/bf00656504 · Cited by 42
Prognostic implications of basophil differentiation in chronic myeloid leukemia
Denburg, J. A., & Browman, G. P. (1988) · American Journal of Hematology · doi:10.1002/ajh.2830270208 · Cited by 39
Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.
Soparker, C. N., O'Brien, J. M., & Albert, D. M. (1993) · PubMed · Cited by 40
Kantarjian, H. M., Shtalrid, M., Kurzrock, R., Buck, M., Dalton, W. T., LeMaistre, A., Stass, S. A., McCredie, K. B., Gutterman, J. U., Freireich, E. J., et al. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90685-7 · Cited by 39
Kaufman, K. M., Snider, J., Spurr, N. K., Schwartz, C. E., & Sodetz, J. M. (1989) · Genomics · doi:10.1016/0888-7543(89)90012-8 · Cited by 39
Self-citationHistone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia
Zhou, M., Zeng, J., Wang, X., Wang, X., Huang, T., Fu, Y., Sun, T., Jia, J., & Chen, C. (2014) · Oncotarget · doi:10.18632/oncotarget.2859 · Cited by 41
“Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by BCR-ABL fusion gene [1].”
BackgroundComparative analysis of cell surface proteins in chronic and acute leukemia cell lines
Lee, S. J., Kim, K., Park, J. Y., Jung, J. W., Kim, Y. H., Kim, S. K., Kim, W., Goh, H.-G., Kim, S.-H., Yoo, J.-S., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.191 · Cited by 38
The Abl SH2‐kinase linker naturally adopts a conformation competent for SH3 domain binding
Chen, S., Brier, S., Smithgall, T. E., & Engen, J. R. (2007) · Protein Science · doi:10.1110/ps.062631007 · Cited by 38
“CML and other Ph-positive leukemias such as acute lymphocytic leukemia (ALL) express a chimeric Bcr-Abl fusion protein with constitutive protein-tyrosine kinase activity (de Klein et al. 1982; Heisterkamp et al. 1983).”
BackgroundLatent Viruses and Mutated Oncogenes: No Evidence for Pathogenicity
DUESBERG, P. H., & Schwarz, J. R. (1992) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)61047-8 · Cited by 38
Gill, G. N., Weber, W., Thompson, D. M., Lin, C. R., Evans, R. M., Rosenfeld, M. G., Gamou, S., & Shimizu, N. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534689 · Cited by 38
Molecular genetics of lung cancer.
Birrer, M. J., & Minna, J. D. (1988) · PubMed · Cited by 38
Heard, J., Fichelson, S., Sola, B., Martial, M. A., Varet, B. R., & Lévy, J. P. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.1.216 · Cited by 38
Soler, G., Radford‐Weiss, I., Abdelali, R. B., Mahlaoui, N., Ponceau, J. F., Macintyre, E. A., Vekemans, M. J. J., Bernard, O., & Romana, S. P. (2007) · Leukemia · doi:10.1038/sj.leu.2405033 · Cited by 37
Diculescu, V. C., Vivan, M., & Oliveira‐Brett, A. M. (2006) · Electroanalysis · doi:10.1002/elan.200603602 · Cited by 37
Interstitial 9q—Deletions in hematologic malignancies
Mecucci, C., Vermaelen, K., Kulling, G., Michaux, J., Noens, L. A., Hove, W. V., Tricot, G. J. K., Louwagie, A. C., & BERGHE, H. V. D. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90064-5 · Cited by 37
Heim, S., Kristoffersson, U., Mandahl, N., Mitelman, F., Békássy, A. N., Garwicz, S., & Wiebe, T. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90155-x · Cited by 37
Bartram, C. R., Janssen, J. W. G., Becher, R., de Klein, A., & Grosveld, G. C. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.5.1389 · Cited by 37
Self-citationHamlyn, P. H., & Sikora, K. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90300-8 · Cited by 37
Revisiting NTRKs as an emerging oncogene in hematological malignancies
Joshi, S. K., Davare, M. A., Druker, B. J., & Tognon, C. E. (2019) · Leukemia · doi:10.1038/s41375-019-0576-8 · Cited by 40
Bhatia, R., Munthe, H. A., Williams, A. D., Zhang, F., Forman, S. J., & Slovak, M. L. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00545-2 · Cited by 36
Gillett, G. T., FOX, M. F., Rowe, P. S., Casimir, C. M., & Povey, S. (1996) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1996.tb00423.x · Cited by 36
Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes
Verhoef, G. E. G., Meeus, P., Stul, M. S., Mecucci, C., Cassiman, J. J., BERGHE, H. V. D., & Boogaerts, M. A. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90209-q · Cited by 36
Identification and characterization of NF1 -related loci on human chromosomes 22, 14 and 2
Hulsebos, T. J. M., Bijleveld, E. H., Riegman, P. H. J., Smink, L. J., & Dunham, I. (1996) · Human Genetics · doi:10.1007/s004390050151 · Cited by 36
Oncogenic intelligence: Oncogene activation by fusion of chromosomes in leukaemia
Adams, J. M. (1985) · Nature · doi:10.1038/315542a0 · Cited by 36
Regulation of Hematopoiesis and Hematological Disease by TGF-β Family Signaling Molecules
Naka, K., & Hirao, A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a027987 · Cited by 40
“2) translocation that generates the BCR-ABL1 fusion oncogene encoding a constitutively active tyrosine kinase (Rowley 1973; de Klein et al. 1982).”
BackgroundValent, P. (2007) · PubMed Central · Cited by 47
Metadata
- Authors
- Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R.
- Affiliations
- Erasmus University Rotterdam (NL)
- National Cancer Institute (US)
- Venue
- Nature
- Published
- 1982-12
- Volume
- 300
- Issue
- 5894
- Pages
- 765-767
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2060833726
- Cited by
- 1,378
- References
- 27
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 12 · 2022: 25 · 2021: 17 · 2020: 18 · 2019: 15 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 33 · 2014: 16 · 2013: 26 · 2012: 33
- FWCI
- 50.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Philadelphia chromosome, chromosome 9, chromosome 22, reciprocal translocation, cellular oncogenes, somatic cell hybrids
- MeSH terms
- Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, DNA, Neoplasm, Gene Expression Regulation, Humans, Leukemia, Myeloid, Oncogenes, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.